Stock listing

Munich:6HV1 Rezolute, Inc. Aktie

German listing (Munich) of Rezolute, Inc. · home listing NASDAQ:RZLT

Follow Rezolute, Inc. into a list and get an email when it puts out news.

Home listing price · NASDAQ:RZLT

$3.92 USD -0.33 (-7.8%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:RZLT

Past year -59.4% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$3.86 – $4.23 USDNov 20, 2026
Volume
2.47M sharesNov 20, 2026
Market cap
$379.2M USDAt the close on Nov 20, 2026 · price × 96.72M shares outstanding
52-week range
$1.07 – $11.17 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$7.16M USDMedian day 1.41M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Rezolute, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:RZLT · Home$3.92 USD-0.33 (-7.8%)2,474,508$4.05$4.23$3.86$4.25Close on Nov 20, 2026
Frankfurt:6HV1€3.72 EUR-0.06 (-1.6%)—€3.74€3.74€3.72€3.78Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:RZLT · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$3.92-0.33-7.8%$4.05$4.23$3.862,474,508
$4.25+0.235+5.9%$3.98$4.30$3.912,931,036
$4.015+0.435+12.2%$3.60$4.035$3.462,886,321
$3.58-0.075-2.1%$3.65$3.68$3.3654,180,174
$3.655-0.215-5.6%$4.56$4.61$3.605,728,608
$3.87-0.20-4.9%$4.06$4.125$3.851,088,444
$4.07+0.05+1.2%$4.10$4.155$3.99974,183
$4.02+0.15+3.9%$3.95$4.205$3.9051,605,339
$3.87-0.01-0.3%$3.99$4.20$3.792,455,325
$3.88+0.24+6.6%$3.67$3.90$3.6051,520,115
$3.64-0.32-8.1%$3.93$3.97$3.5641,227,828
$3.96-0.05-1.2%$4.12$4.34$3.951,074,149
$4.01+0.13+3.4%$3.94$4.13$3.90919,232
$3.88-0.07-1.8%$3.98$4.02$3.745844,863
$3.95-0.17-4.1%$4.05$4.16$3.88779,004
$4.12-0.10-2.4%$4.20$4.33$4.075756,226
$4.22+0.11+2.7%$4.11$4.235$4.021,414,466
$4.11+0.29+7.6%$3.80$4.14$3.7791,400,113
$3.82-0.035-0.9%$3.87$3.89$3.7351,543,500
$3.855-0.005-0.1%$3.78$3.938$3.701,198,100
$3.86+0.16+4.3%$3.67$3.965$3.671,355,600
$3.700.000.0%$3.70$3.785$3.645930,000
$3.700.000.0%$3.66$3.84$3.631,225,900
$3.70+0.12+3.4%$3.62$3.72$3.371,778,900
$3.58-0.32-8.2%$3.90$3.99$3.561,397,900
$3.90-0.33-7.8%$4.25$4.33$3.902,118,600
$4.23-0.38-8.2%$4.52$4.70$4.211,693,700
$4.61-0.26-5.3%$4.825$4.85$4.561,507,700
$4.870.000.0%$4.86$4.91$4.721,009,600
$4.87+0.23+5.0%$4.60$4.91$4.551,872,900
$4.64+0.26+5.9%$4.33$4.685$4.322,197,700
$4.38+0.06+1.4%$4.29$4.56$4.231,689,800
$4.32-0.01-0.2%$4.64$4.64$4.152,191,800
$4.33+0.32+8.0%$4.05$4.535$3.824,197,500
$4.01-0.06-1.5%$4.13$4.20$3.9651,646,300
$4.07-0.07-1.7%$4.14$4.175$4.04981,200
$4.14+0.05+1.2%$4.19$4.345$4.1351,702,800
$4.09-0.09-2.2%$4.545$4.57$4.071,517,800
$4.18+0.28+7.2%$3.85$4.195$3.761,587,600
$3.90-0.04-1.0%$3.99$4.05$3.8712,046,700
$3.94-0.06-1.5%$4.03$4.085$3.8353,868,200
$4.00-0.04-1.0%$4.05$4.13$3.981,683,200
$4.04+0.13+3.3%$3.96$4.09$3.95928,500
$3.91+0.07+1.8%$3.84$3.93$3.731,082,700
$3.84-0.11-2.8%$3.95$3.95$3.6652,527,200
$3.95-0.03-0.8%$4.09$4.14$3.8851,832,100
$3.98-0.17-4.1%$4.20$4.23$3.8752,044,200
$4.15-0.10-2.4%$4.28$4.28$4.11753,000
$4.25+0.03+0.7%$4.18$4.28$4.09828,000
$4.22+0.05+1.2%$4.23$4.355$4.081,352,700
$4.17+0.11+2.7%$4.03$4.35$3.972,224,300
$4.06-0.34-7.7%$4.55$4.55$4.022,071,900
$4.40-0.18-3.9%$4.51$4.53$4.37866,100
$4.58+0.04+0.9%$4.49$4.62$4.44716,900
$4.54-0.02-0.4%$4.59$4.615$4.47771,900
$4.56+0.06+1.3%$4.50$4.61$4.43857,300
$4.50-0.19-4.1%$4.64$4.71$4.431,020,400
$4.69+0.07+1.5%$4.65$4.74$4.60749,100
$4.62-0.36-7.2%$4.95$4.95$4.581,084,900
$4.98-0.06-1.2%$5.07$5.081$4.935784,200
$5.04+0.03+0.6%$5.01$5.10$4.8751,368,000
$5.010.000.0%$4.94$5.22$4.941,798,771
$5.01-0.08-1.6%$5.03$5.13$4.701,297,415
$5.09+0.43+9.2%$4.68$5.635$4.6466,500,000
$4.66-0.06-1.3%$4.68$4.71$4.60971,400

Splits

3 splits since 2013 · NASDAQ:RZLT · every price before a split is adjusted for it

DayRatioWhat
1-for-50Consolidation
1-for-6Consolidation
6-for-1Split
Ticker
Munich:6HV1
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Munich
Currency
EUR

What changed lately

Latest news

All Rezolute, Inc. news

Rezolute, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
20 in the last 12 months · 124 in all · newest Nov 13, 2026 · oldest 2019
Decks
29 decks · latest November 2026

Where Rezolute, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:RZLT · Home listingNASDAQUnited StatesUSD
LS Exchange:A2QEWPLS ExchangeGermanyEUR
BOATS:RZLTBOATSUnited StatesUSD
Lang & Schwarz:A2QEWPLang & SchwarzGermanyEUR
Dusseldorf:6HV1DusseldorfGermanyEUR
Frankfurt:6HV1FrankfurtGermanyEUR
Munich:6HV1 · This pageMunichGermanyEUR
Stuttgart:6HV1StuttgartGermanyEUR
Tradegate:6HV1TradegateGermanyEUR

Valuation

Price/book 4.4× against a median of 4.1×: 7th lowest of 10 Biotechnology companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$289.9M USD
P/E
Loss
EV/sales
No revenue
EV/EBITDA
Negative EBITDA
Price/book
4.4×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.0×
Beta vs S&P 500
1.28

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Rezolute, Inc. · NASDAQ:RZLTUS$379.2MUS$289.9Mn/an/an/a4.4×n/a0.0×1.28
Mezzion Pharma Co., Ltd. · KRX:140410US$391.0MUS$360.8Mn/a57.3×n/a13.4×−325.0%0.0×n/a
Avalo Therapeutics, Inc. · NASDAQ:AVTXUS$390.9M−US$1.93Mn/an/an/a0.9×n/a0.0×1.25
Qurient Co., Ltd. · KRX:115180US$388.5MUS$372.4Mn/a70.5×n/a30.2×−543.0%0.8×n/a
Beijing Luzhu Biotechnology Co., Ltd. Class H · HKEX:2480US$388.2MUS$369.1Mn/an/an/a4.3×n/a0.4×n/a
Hanx Biopharmaceuticals (Wuhan) Co. Ltd. Class H · HKEX:3378US$387.5MUS$316.0Mn/an/an/a4.1×n/a0.1×n/a
Opus Genetics, Inc. · NASDAQ:IRDUS$385.7MUS$332.3Mn/a42.0×n/a10.0×n/a0.9×1.01
Eupraxia Pharmaceuticals, Inc. · TSX:EPRXUS$384.3MUS$252.7Mn/an/an/a2.9×n/a0.0×1.53
Hinova Pharmaceuticals, Inc. Class A · SSE:688302US$381.1MUS$285.9Mn/a23.0×n/a2.6×−167.3%0.1×n/a
Phathom Pharmaceuticals, Inc. · NASDAQ:PHATUS$378.8MUS$359.8Mn/a1.3×n/an/a−30.2%n/a1.08
Qyuns Therapeutics Co., Ltd. Class H · HKEX:2509US$370.7MUS$380.5M4.5×2.5×4.2×2.9×53.3%0.8×n/a
Median of the othersUS$386.6MUS$346.1M4.5×32.5×4.2×4.1×−167.3%0.1×1.17

Forecasts

9 strong buy · 2 buy · Analysts' consensus from EODHD, read Nov 20, 2026. Not 6ix's view and not investment advice.

Price target
10.80 USD · Analysts' mean
EPS, year to Jun 2027
-0.65 · 8 analysts
Revenue, year to Jun 2027
2.09M · 11 analysts

Team and board

Officers

OfficerRole
Nevan Charles ElamChief Executive Officer & Founder
Daron EvansChief Financial and Business Officer
Michael R. DeperroSenior Vice President & Head of Operations
Brian RobertsChief Medical Officer
Erik HarrisBoard Member
Nerissa KreherBoard Member
Sunil KarnawatChief Commercial Officer
Susan StewartChief Regulatory Officer
Vlad HogenhuisBoard Member

Board

DirectorRole
Erik HarrisBoard Member
Gil LabrucherieBoard Member
Nerissa KreherBoard Member
Nevan Charles ElamChief Executive Officer & Founder
Philippe FauchetBoard Member
Vlad HogenhuisBoard Member
Young-Jin KimBoard Member

Events

Next results
Feb 11, 2027 (expected)
QuarterResultsShare move
Q1 2027Nov 5, 2026 · After close+6.6%
Q4 2026Sep 24, 2026 · After close−1.0%
Q3 2026May 13, 2026+3.0%
Q2 2026Feb 12, 2026 · After close+5.8%
Q1 2026Nov 6, 2025 · After close+12.1%
Q4 2025Sep 17, 2025+6.2%
Q3 2025May 13, 2025 · After close−4.9%
Q2 2025Feb 12, 2025 · After close−1.0%
Q1 2025Nov 7, 2024 · After close−2.5%
Q4 2024Sep 19, 2024 · After close+5.4%
All 20 quarters
QuarterResultsShare move
Q3 2024May 15, 2024 · After close−3.4%
Q2 2024Feb 13, 2024 · After close+13.8%
Q1 2024Nov 13, 2023 · After close−7.4%
Q4 2023Sep 14, 2023 · After close0.0%
Q3 2023May 11, 2023 · After close+2.0%
Q2 2023Feb 10, 2023 · After close−3.2%
Q1 2023Nov 9, 2022 · After close0.0%
Q4 2022Sep 15, 2022 · After close+0.4%
Q3 2022May 12, 2022 · After close+6.2%
Q2 2022Feb 9, 2022 · After close−0.7%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (November 2026)Investor deck35 slidesNovember 2026
Investor Presentation (October 2026)Investor deck34 slidesOctober 2026
Investor Presentation (August 2026)Investor deck31 slidesAugust 2026
Investor Presentation (June 2026)Investor deck31 slidesJune 2026
Investor Presentation (May 2026)Investor deck38 slidesMay 2026
Investor Presentation (March 2026)Investor deck35 slidesMarch 2026
Investor Presentation (February 2026)Investor deck34 slidesFebruary 2026
Investor Presentation (January 2026)Investor deck34 slidesJan 7, 2026
Investor Presentation (January 2026)Investor deck35 slidesJanuary 2026
Investor Day (November 2025)Investor day40 slidesNov 12, 2025
All 29 decks
DeckKindSlidesDate
Investor Day (November 2025)Investor day40 slidesNov 10, 2025
Investor Presentation (November 2025)Investor deck29 slidesNovember 2025
Investor Presentation (September 2025)Investor deck28 slidesSep 2, 2025
Investor Presentation (September 2025)Investor deck27 slidesSeptember 2025
Investor Presentation (May 2025)Investor deck27 slidesMay 2025
Investor Presentation (April 2025)Investor deck27 slidesApril 2025
Investor Presentation (February 2025)Investor deck26 slidesFebruary 2025
Investor Presentation (November 2024)Investor deck26 slidesNovember 2024
Investor Presentation (October 2024)Investor deck26 slidesOctober 2024
Investor Presentation (August 2024)Investor deck27 slidesAug 5, 2024
Technical Presentation (June 2024)Technical23 slidesJun 28, 2024
Technical Presentation (May 2022)Technical18 slidesMay 2, 2022
Technical Presentation (2022)Technical13 slides2022
Technical Presentation (May 2020)Technical14 slidesMay 30, 2020
CHI Vienna Presentation (September 2019)Conference20 slidesSep 22, 2019
Investor Presentation (June 2019)Investor deck26 slidesJun 17, 2019
AntriaBio — Investor Presentation (September 2015)Investor deck31 slidesSep 30, 2015
AntriaBio — American Diabetes Association 75th Scientific Sessions 2015Conference12 slidesJun 8, 2015
AntriaBio — Investor Presentation (February 2014)Investor deck17 slidesFeb 5, 2014

Open Decks

Financings

RaiseDate
Public offering of common stock and pre-funded warrants
Announced: about US$100M · US$3.87 a share · Morgan Stanley +6
Dealers: Morgan Stanley (co-lead), Guggenheim Securities (co-lead), Cantor (co-lead), H.C. Wainwright & Co., Jones, Maxim Group LLC, Lake Street Capital Markets, LLC
Buyers: Frazier Life Sciences
Use of proceeds: Ersodetug commercialization preparation, working capital and general corporate purposes
Nov 13, 2026
Public offering of common stock and pre-funded warrants
Closed: US$96.9M raised · US$3.25 a share · Guggenheim Securities +6
Dealers: Guggenheim Securities (lead), BTIG (co-lead), H.C. Wainwright & Co. (co-lead), Jones (co-lead), Craig-Hallum, Maxim Group LLC, WG Partners LLP
Buyers: Federated Hermes Kaufmann Funds; Blackstone Multi-Asset Investing; Great Point Partners, LLC; Marshall Wace; Woodline Partners LP; Nantahala Capital; Squadron Capital Management
Use of proceeds: Research and development, general corporate expenses and working capital needs
Apr 25, 2025
Private placement of shares of common stock
Announced: up to US$4.2M
Apr 25, 2025

Open Financings · Read by 6ix AI from the company's releases

Financials

Annual, in USD

Income statement

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue0000000000
Cost of revenue31.0K31.0K36.0K382.0K256.0K13.0K18.0K48.0K012.6M
Gross profit-31.0K-31.0K-36.0K-382.0K-256.0K-13.0K-18.0K-48.0K0-12.6M
Research and development53.8M61.5M55.7M43.8M32.5M15.0M14.4M19.1M17.3M12.1M
Selling, general and administrative29.2M18.4M14.7M12.2M9.36M7.91M6.07M6.82M9.10M8.23M
Operating income-83.0M-79.9M-70.4M-56.0M-41.8M-22.9M-20.5M-25.9M-28.7M-20.3M
Depreciation and amortization31.0K31.0K36.0K30.0K13.0K13.0K18.0K49.0K1.07M1.11M
EBITDA-82.9M-79.9M-70.4M-56.0M-41.8M-22.9M-20.5M-25.9M-27.7M-19.2M
Interest expense919.0K1.81M375.0K04.96M689.0K1.59K
Income before tax-77.6M-74.4M-68.5M-51.8M-41.1M-20.9M-20.3M-30.4M-29.9M-20.3M
Income tax0000000000
Net income-77.6M-74.4M-68.5M-51.8M-41.1M-20.9M-20.3M-30.4M-29.9M-20.3M
Earnings per share, basic-0.75-0.98-1.33-1.01-2.26-2.72-3.54-18.41-0.54-0.57
Earnings per share, diluted-0.75-0.98-1.33-1.01-2.32-2.72-3.54-18.41-0.54-0.57

Balance sheet

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents10.6M94.1M70.4M16.0M150.4M41.0M77.4M37.6M1.65M4.49M
Short-term investments97.2M73.8M56.5M85.9M0
Receivables500.0K700.0K
Current assets110.5M171.1M128.7M104.9M152.1M42.0M10.5M12.1M2.01M4.93M
Property, plant and equipment41.0K72.0K103.0K139.0K16.0K29.0K33.0K44.0K368.0K5.33M
Total assets112.8M175.5M132.7M123.7M152.4M42.6M11.0M12.3M2.50M10.6M
Accounts payable5.03M5.81M4.90M3.27M1.13M1.03M893.0K563.0K1.71M926.0K
Current liabilities11.4M11.9M9.61M5.20M2.46M1.97M3.23M8.38M6.25M1.77M
Long-term debt407.0K14.0M
Total debt934.0K1.61M2.23M2.48M515.0K14.0M003.42M10.0K
Total liabilities12.2M13.4M11.7M7.55M2.95M16.5M3.60M10.5M6.46M2.10M
Shareholders' equity100.7M162.1M121.0M116.2M149.5M26.1M7.37M1.75M-3.96M8.53M
Shares outstanding96.4M87.0M53.2M36.8M33.6M8.35M5.87M4.21M62.2K49.2M

Cash flow

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations-64.6M-69.1M-57.4M-44.5M-39.6M-20.4M-24.2M-15.3M-14.1M-13.3M
Capital spending000-153.0K-153.0K-153.0K0-47.0K-6.00K-407.9K
Free cash flow-64.6M-69.1M-57.4M-44.6M-39.6M-20.4M-24.2M-15.4M-14.1M-13.7M
Cash from investing-21.1M-14.5M48.7M-101.5M-101.5M00231.0K1.73M-195.4K
Cash from financing2.24M107.3M63.0M11.6M149.0M51.5M22.6M25.0M9.54M13.9M
Share buybacks-3.00K179.8M14.6M
Change in cash-83.5M23.7M54.4M-134.4M109.4M31.1M-1.62M9.93M-2.84M424.5K

Open Financials

Filings

FilingDateTypeFiled with
SCHEDULE 13G · Big-stake noticeNov 19, 2026Big-stake noticeSEC
8-K · Current reportNov 16, 2026Material contractSEC
424B5 · ProspectusNov 16, 2026Offer documentSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 13, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeNov 13, 2026Big-stake noticeSEC
8-K · Current reportNov 13, 2026Current reportSEC
FWP · Free writing prospectusNov 13, 2026Offer documentSEC
424B5 · ProspectusNov 13, 2026Offer documentSEC
EFFECT · Notice that a registration is effectiveNov 12, 2026Other filingsSEC
S-3 · Registration statementNov 5, 2026Offer documentSEC
Show 200 filings
FilingDateTypeFiled with
10-Q · Quarterly reportNov 5, 2026Quarterly reportSEC
8-K · Current reportNov 5, 2026ResultsSEC
8-K · Current reportOct 29, 2026Current reportSEC
SCHEDULE 13G · Big-stake noticeOct 28, 2026Big-stake noticeSEC
4 · Change in ownershipOct 23, 2026Insider tradeSEC
DEF 14A · Proxy statementOct 21, 2026Meeting noticeSEC
DRS · Draft registration statementOct 15, 2026Offer documentSEC
8-K · Current reportOct 14, 2026Current reportSEC
PRE 14A · Preliminary proxy statementOct 7, 2026Meeting noticeSEC
8-K · Current reportOct 5, 2026Current reportSEC
10-K · Annual reportSep 24, 2026Annual reportSEC
8-K · Current reportSep 24, 2026ResultsSEC
4 · Change in ownershipSep 3, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 12, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeAug 12, 2026Big-stake noticeSEC
4 · Change in ownershipJul 7, 2026Insider tradeSEC
4 · Change in ownershipJul 7, 2026Insider tradeSEC
4 · Change in ownershipJul 7, 2026Insider tradeSEC
8-K · Current reportJun 2, 2026Current reportSEC
SCHEDULE 13G · Big-stake noticeMay 15, 2026Big-stake noticeSEC
10-Q · Quarterly reportMay 12, 2026Quarterly reportSEC
8-K · Current reportMay 12, 2026ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 11, 2026Big-stake noticeSEC
8-K · Current reportMay 4, 2026Current reportSEC
4 · Change in ownershipMar 31, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMar 26, 2026Big-stake noticeSEC
8-K · Current reportMar 24, 2026Current reportSEC
4 · Change in ownershipMar 4, 2026Insider tradeSEC
4 · Change in ownershipMar 4, 2026Insider tradeSEC
4 · Change in ownershipMar 4, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 13, 2026Big-stake noticeSEC
10-Q · Quarterly reportFeb 12, 2026Quarterly reportSEC
8-K · Current reportFeb 12, 2026ResultsSEC
SCHEDULE 13G · Big-stake noticeFeb 11, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeJan 30, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedJan 8, 2026Big-stake noticeSEC
8-K · Current reportJan 7, 2026Current reportSEC
SCHEDULE 13G · Big-stake noticeDec 19, 2025Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeDec 18, 2025Big-stake noticeSEC
4 · Change in ownershipDec 17, 2025Insider tradeSEC
4 · Change in ownershipDec 17, 2025Insider tradeSEC
4 · Change in ownershipDec 15, 2025Insider tradeSEC
4 · Change in ownershipDec 15, 2025Insider tradeSEC
4 · Change in ownershipDec 15, 2025Insider tradeSEC
S-3ASR · Registration statementDec 5, 2025Offer documentSEC
4 · Change in ownershipNov 21, 2025Insider tradeSEC
4 · Change in ownershipNov 21, 2025Insider tradeSEC
4 · Change in ownershipNov 21, 2025Insider tradeSEC
4 · Change in ownershipNov 21, 2025Insider tradeSEC
S-8 · Registration statement for employee plansNov 21, 2025Offer documentSEC
4 · Change in ownershipNov 21, 2025Insider tradeSEC
4 · Change in ownershipNov 21, 2025Insider tradeSEC
4 · Change in ownershipNov 21, 2025Insider tradeSEC
8-K · Current reportNov 21, 2025Meeting outcomeSEC
4 · Change in ownershipNov 21, 2025Insider tradeSEC
4 · Change in ownershipNov 21, 2025Insider tradeSEC
4 · Change in ownershipNov 21, 2025Insider tradeSEC
8-K · Current reportNov 12, 2025Current reportSEC
10-Q · Quarterly reportNov 6, 2025Quarterly reportSEC
8-K · Current reportNov 6, 2025ResultsSEC
8-K · Current reportOct 21, 2025Material contractSEC
SCHEDULE 13G · Big-stake noticeOct 17, 2025Big-stake noticeSEC
DEF 14A · Proxy statementOct 7, 2025Meeting noticeSEC
SCHEDULE 13G · Big-stake noticeSep 22, 2025Big-stake noticeSEC
10-K · Annual reportSep 17, 2025Annual reportSEC
8-K · Current reportSep 17, 2025ResultsSEC
8-K · Current reportSep 2, 2025Current reportSEC
4 · Change in ownershipAug 27, 2025Insider tradeSEC
3 · Initial statement of ownershipAug 27, 2025Insider tradeSEC
8-K · Current reportAug 20, 2025Material contractSEC
EFFECT · Notice that a registration is effectiveAug 11, 2025Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 6, 2025Big-stake noticeSEC
CORRESP · Letter to the SECAug 1, 2025Other filingsSEC
UPLOAD · Letter from the SECJul 24, 2025Other filingsSEC
8-K · Current reportJul 18, 2025Current reportSEC
S-3 · Registration statementJul 17, 2025Offer documentSEC
4 · Change in ownershipJun 26, 2025Insider tradeSEC
4 · Change in ownershipJun 24, 2025Insider tradeSEC
4 · Change in ownershipJun 23, 2025Insider tradeSEC
4 · Change in ownershipJun 23, 2025Insider tradeSEC
4 · Change in ownershipJun 13, 2025Insider tradeSEC
8-K/A · Current report, amendedJun 13, 2025Management or board changeSEC
8-K · Current reportJun 13, 2025FinancingSEC
4 · Change in ownershipJun 13, 2025Insider tradeSEC
4 · Change in ownershipJun 13, 2025Insider tradeSEC
4 · Change in ownershipJun 12, 2025Insider tradeSEC
4 · Change in ownershipJun 12, 2025Insider tradeSEC
4 · Change in ownershipJun 12, 2025Insider tradeSEC
4 · Change in ownershipJun 12, 2025Insider tradeSEC
4 · Change in ownershipJun 12, 2025Insider tradeSEC
10-Q · Quarterly reportMay 13, 2025Quarterly reportSEC
8-K · Current reportMay 13, 2025ResultsSEC
8-K · Current reportApr 28, 2025Current reportSEC
8-K · Current reportApr 23, 2025Material contractSEC
424B5 · ProspectusApr 23, 2025Offer documentSEC
424B5 · ProspectusApr 23, 2025Offer documentSEC
8-K · Current reportApr 23, 2025Current reportSEC
4 · Change in ownershipApr 1, 2025Insider tradeSEC
4 · Change in ownershipMar 31, 2025Insider tradeSEC
8-K · Current reportMar 28, 2025Management or board changeSEC
4 · Change in ownershipMar 28, 2025Insider tradeSEC
4 · Change in ownershipMar 26, 2025Insider tradeSEC
3 · Initial statement of ownershipMar 26, 2025Insider tradeSEC
SCHEDULE 13G · Big-stake noticeMar 7, 2025Big-stake noticeSEC
4 · Change in ownershipFeb 20, 2025Insider tradeSEC
4 · Change in ownershipFeb 20, 2025Insider tradeSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 14, 2025Big-stake noticeSEC
10-Q · Quarterly reportFeb 12, 2025Quarterly reportSEC
8-K · Current reportFeb 12, 2025ResultsSEC
8-K · Current reportFeb 4, 2025Current reportSEC
8-K · Current reportJan 14, 2025Current reportSEC
8-K · Current reportJan 7, 2025Current reportSEC
S-8 · Registration statement for employee plansDec 30, 2024Offer documentSEC
4 · Change in ownershipDec 18, 2024Insider tradeSEC
4 · Change in ownershipDec 12, 2024Insider tradeSEC
8-K · Current reportDec 10, 2024Meeting outcomeSEC
4 · Change in ownershipDec 10, 2024Insider tradeSEC
SC 13G/A · Big-stake notice, amendedNov 14, 2024Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 14, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedNov 14, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedNov 13, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedNov 12, 2024Big-stake noticeSEC
10-Q · Quarterly reportNov 7, 2024Quarterly reportSEC
8-K · Current reportNov 7, 2024ResultsSEC
DEFA14A · Additional proxy materialOct 21, 2024Meeting noticeSEC
DEF 14A · Proxy statementOct 21, 2024Meeting noticeSEC
PRE 14A · Preliminary proxy statementOct 10, 2024Meeting noticeSEC
4 · Change in ownershipSep 24, 2024Insider tradeSEC
4 · Change in ownershipSep 24, 2024Insider tradeSEC
10-K · Annual reportSep 19, 2024Annual reportSEC
8-K · Current reportSep 19, 2024ResultsSEC
8-K · Current reportSep 9, 2024Current reportSEC
EFFECT · Notice that a registration is effectiveAug 15, 2024Other filingsSEC
CORRESP · Letter to the SECAug 13, 2024Other filingsSEC
S-3/A · Registration statement, amendedAug 9, 2024Offer documentSEC
UPLOAD · Letter from the SECAug 9, 2024Other filingsSEC
S-3 · Registration statementAug 5, 2024Offer documentSEC
8-K · Current reportAug 5, 2024Current reportSEC
8-K · Current reportJun 28, 2024Current reportSEC
4 · Change in ownershipJun 27, 2024Insider tradeSEC
8-K · Current reportJun 27, 2024Material contractSEC
8-K · Current reportJun 14, 2024Material contractSEC
424B5 · ProspectusJun 14, 2024Offer documentSEC
4 · Change in ownershipJun 14, 2024Insider tradeSEC
4 · Change in ownershipJun 14, 2024Insider tradeSEC
424B5 · ProspectusJun 13, 2024Offer documentSEC
4 · Change in ownershipMay 31, 2024Insider tradeSEC
4 · Change in ownershipMay 28, 2024Insider tradeSEC
4 · Change in ownershipMay 28, 2024Insider tradeSEC
8-K · Current reportMay 24, 2024Current reportSEC
8-K · Current reportMay 17, 2024Meeting outcomeSEC
10-Q · Quarterly reportMay 15, 2024Quarterly reportSEC
8-K · Current reportMay 15, 2024ResultsSEC
8-K · Current reportApr 25, 2024Current reportSEC
DEF 14A · Proxy statementApr 12, 2024Meeting noticeSEC
4 · Change in ownershipMar 29, 2024Insider tradeSEC
4 · Change in ownershipMar 19, 2024Insider tradeSEC
4 · Change in ownershipMar 19, 2024Insider tradeSEC
4 · Change in ownershipMar 18, 2024Insider tradeSEC
4/A · Change in ownership, amendedMar 18, 2024Insider tradeSEC
8-K · Current reportMar 14, 2024Material contractSEC
4 · Change in ownershipMar 14, 2024Insider tradeSEC
8-K · Current reportMar 11, 2024Current reportSEC
SC 13G · Big-stake noticeMar 11, 2024Big-stake noticeSEC
4 · Change in ownershipMar 11, 2024Insider tradeSEC
4 · Change in ownershipMar 8, 2024Insider tradeSEC
4 · Change in ownershipFeb 28, 2024Insider tradeSEC
4 · Change in ownershipFeb 27, 2024Insider tradeSEC
8-K · Current reportFeb 22, 2024Current reportSEC
4 · Change in ownershipFeb 21, 2024Insider tradeSEC
4 · Change in ownershipFeb 20, 2024Insider tradeSEC
SC 13G/A · Big-stake notice, amendedFeb 13, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 13, 2024Big-stake noticeSEC
10-Q · Quarterly reportFeb 13, 2024Quarterly reportSEC
8-K · Current reportFeb 13, 2024ResultsSEC
SC 13G/A · Big-stake notice, amendedFeb 12, 2024Big-stake noticeSEC
8-K · Current reportJan 29, 2024Management or board changeSEC
4 · Change in ownershipJan 25, 2024Insider tradeSEC
3 · Initial statement of ownershipJan 25, 2024Insider tradeSEC
4 · Change in ownershipJan 25, 2024Insider tradeSEC
4 · Change in ownershipJan 25, 2024Insider tradeSEC
4 · Change in ownershipJan 25, 2024Insider tradeSEC
4 · Change in ownershipJan 25, 2024Insider tradeSEC

This page holds 200 of 768 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Rezolute, Inc.’s releases · as of Nov 13, 2026

Common shares
96,722,333
Fully diluted
96,722,333

Fully diluted

LineSharesAs of
Common shares96,722,333Sep 21, 2026

Share count over time

CountShares
Sep 21, 202696,722,333

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Federated Hermes, Inc.12.9M13.4%US$53.6MSep 30, 2026
Ra Capital Management, L.P.9.45M9.8%US$39.1MSep 30, 2026
BlackRock8.27M8.6%US$34.2MSep 30, 2026
Vanguard5.55M5.7%US$23MSep 30, 2026
Jennison Associates LLC5.33M5.5%US$22.1MSep 30, 2026
Opaleye Management Inc.4.09M4.2%US$16.9MSep 30, 2026
Balyasny Asset Management L.P.3.77M3.9%US$15.6MSep 30, 2026
Siren, L.L.C.3.33M3.4%US$13.8MSep 30, 2026
D. E. Shaw & Co., Inc.2.39M2.5%US$9.89MSep 30, 2026
Geode Capital2.13M2.2%US$8.84MSep 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
State Street1.83M1.9%US$7.57MSep 30, 2026
Kennedy Capital Management LLC1.67M1.7%US$6.92MSep 30, 2026
Vestal Point Capital, LP1.46M1.5%US$6.02MSep 30, 2026
Millennium1.36M1.4%US$5.61MSep 30, 2026
Affinity Asset Advisors, LLC1M1.0%US$4.14MSep 30, 2026
Dimensional992K1.0%US$4.11MSep 30, 2026
Schonfeld Strategic Advisors LLC980K1.0%US$4.06MSep 30, 2026
Great Point Partners LLC952K0.98%US$3.94MSep 30, 2026
AQR Capital Management LLC940K0.97%US$3.89MSep 30, 2026
Ikarian Capital, LLC935K0.97%US$3.87MSep 30, 2026
Blue Owl Capital Holdings LP935K0.97%US$3.87MSep 30, 2026
Jacobs Levy Equity Management, Inc932K0.96%US$3.86MSep 30, 2026
Goldman Sachs886K0.92%US$3.67MSep 30, 2026
Schwab721K0.75%US$2.98MSep 30, 2026
Two Sigma711K0.74%US$2.95MSep 30, 2026
Northern Trust697K0.72%US$2.89MSep 30, 2026
Driehaus Capital Management LLC697K0.72%US$2.89MSep 30, 2026
Woodline Partners LP612K0.63%US$2.53MSep 30, 2026
Citadel584K0.60%US$2.42MSep 30, 2026
Fidelity454K0.47%US$1.88MSep 30, 2026
Gsa Capital Partners LLP421K0.44%US$1.74MSep 30, 2026
J. Goldman & Co LP407K0.42%US$1.69MSep 30, 2026
Barclays377K0.39%US$1.56MSep 30, 2026
Janus Henderson340K0.35%US$1.41MSep 30, 2026
XTX Topco Ltd331K0.34%US$1.37MSep 30, 2026
Jane Street322K0.33%US$1.33MSep 30, 2026
Susquehanna304K0.31%US$1.26MSep 30, 2026
Morgan Stanley289K0.30%US$1.2MSep 30, 2026
Boothbay Fund Management, LLC287K0.30%US$1.19MSep 30, 2026
Wellington279K0.29%US$1.15MSep 30, 2026
Russell Investments Group, Ltd.259K0.27%US$1.07MSep 30, 2026
Los Angeles Capital Management LLC242K0.25%US$1MSep 30, 2026
Hrt Financial LP230K0.24%US$952KSep 30, 2026
BNY223K0.23%US$923KSep 30, 2026
ExodusPoint Capital Management, LP218K0.23%US$902KSep 30, 2026
Jump Financial, LLC217K0.22%US$899KSep 30, 2026
Nuveen203K0.21%US$841KSep 30, 2026
Knott David M Jr160K0.17%US$661KSep 30, 2026
Creative Planning157K0.16%US$650KSep 30, 2026
JPMorgan152K0.16%US$621KSep 30, 2026

This page holds 50 of 133 holders. Open Shareholders

Funds

HolderSharesOf the companyValueAs of
Federated Hermes Kaufmann Fund7.48M7.7%US$35.3MJul 31, 2026
Federated Hermes Kaufmann Small Cap Fund5.34M5.5%US$25.2MJul 31, 2026
Vanguard Total Stock Market Index Fund2.74M2.8%US$14.3MJun 30, 2026
iShares Russell 2000 ETF2.07M2.1%US$10.7MJun 30, 2026
Vanguard Extended Market Index Fund1.01M1.0%US$5.23MJun 30, 2026
Fidelity Small Cap Index Fund857K0.89%US$4.04MJul 31, 2026
iShares Russell 2000 Value ETF637K0.66%US$3.31MJun 30, 2026
Vanguard Strategic Small-Cap Equity Fund629K0.65%US$3.27MJun 30, 2026
Fidelity Extended Market Index Fund451K0.47%US$1.49MMay 31, 2026
Schwab U.S. Small-Cap ETF412K0.43%US$1.36MMay 31, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Vanguard Russell 2000 Index Fund372K0.38%US$1.23MMay 31, 2026
Janus Henderson Small Cap Growth Alpha ETF321K0.33%US$1.51MJul 31, 2026
Dimensional U.S. Small Cap ETF320K0.33%US$1.51MJul 31, 2026
iShares Micro-Cap ETF263K0.27%US$1.37MJun 30, 2026
College Retirement Equities Fund - Total Global Stock Account239K0.25%US$1.24MJun 30, 2026
Vanguard U.S. Momentum Factor ETF219K0.23%US$722KMay 31, 2026
Vanguard Health Care Index Fund217K0.22%US$715KMay 31, 2026
BlackRock Advantage Small Cap Core Fund197K0.20%US$649KMay 29, 2026
Schwab Small-Cap Index Fund190K0.20%US$899KJul 31, 2026
Federated Hermes Kaufmann Fund II166K0.17%US$862KJun 30, 2026
U.S. Small Cap Portfolio158K0.16%US$745KJul 31, 2026
Fidelity Enhanced Small Cap Core ETF155K0.16%US$807KJun 30, 2026
Master Small Cap Index Series155K0.16%US$807KJun 30, 2026
Fidelity Total Market Index Fund152K0.16%US$503KMay 31, 2026
U.S. Micro Cap Portfolio144K0.15%US$680KJul 31, 2026
Fidelity Series Total Market Index Fund131K0.14%US$432KMay 31, 2026
iShares Core S&P Total U.S. Stock Market ETF120K0.12%US$623KJun 30, 2026
BlackRock Advantage Small Cap Growth Fund119K0.12%US$620KJun 30, 2026
Goldman Sachs ActiveBeta(R) U.S. Small Cap Equity ETF117K0.12%US$387KMay 31, 2026
Nuveen Small Cap Blend Index Fund104K0.11%US$492KJul 31, 2026
ALPS Medical Breakthroughs ETF98,6430.10%US$326KMay 31, 2026
iShares Russell 2000 Growth ETF97,9140.10%US$509KJun 30, 2026
Fidelity Small Cap Value Index Fund94,9750.10%US$494KJun 30, 2026
EQ/2000 Managed Volatility Portfolio85,5280.09%US$445KJun 30, 2026
Virtus Biotech Clinical Trials Etf77,7050.08%US$367KJul 31, 2026
AlphaCentric Life Sciences and Healthcare Fund72,2550.07%US$376KJun 30, 2026
Nuveen Equity Index Fund71,3530.07%US$337KJul 31, 2026
U.S. Small Cap Equity Fund62,9830.07%US$297KJul 31, 2026
Schwab Total Stock Market Index Fund60,2570.06%US$284KJul 31, 2026
Fidelity Nasdaq Composite Index Fund60,1270.06%US$198KMay 31, 2026
Vanguard Russell 2000 Growth Index Fund58,1770.06%US$192KMay 31, 2026
PACE Small/Medium Co Growth Equity Investments56,5060.06%US$267KJul 31, 2026
Goldman Sachs Small Cap Growth Insights Fund54,9790.06%US$260KJul 31, 2026
VIP Disciplined Small Cap Portfolio53,7740.06%US$280KJun 30, 2026
Dimensional U.S. Core Equity 2 ETF50,2030.05%US$237KJul 31, 2026
LVIP State Street Small-Cap Index Fund48,8000.05%US$254KJun 30, 2026
NVIT Multi-Manager Small Company Fund47,3000.05%US$246KJun 30, 2026
Vanguard Balanced Index Fund47,1290.05%US$245KJun 30, 2026
Fidelity ZERO Total Market Index Fund46,9220.05%US$221KJul 31, 2026
NVIT Small Cap Value Fund42,8000.04%US$223KJun 30, 2026

This page holds 50 of 143 holders. Open Shareholders

Big stakes

StakeStakeSharesDateFiling
Ra Capital Management, L.P.9.90%9.18MDec 11, 2025Schedule 13G
Raymond Debbane6.10%7.2MNov 13, 2026Schedule 13G
Dellora Investments LP5.90%5.72MAug 5, 2026Schedule 13G
Prudential Financial Inc5.50%5.34MSep 30, 2026Schedule 13G
Jennison Associates LLC5.50%5.33MSep 30, 2026Schedule 13G
BlackRock, Inc.5.40%4.88MSep 30, 2025Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Erik Harris
Other companies: Ultragenyx Pharmaceutical Inc. (EVP & Chief Commercial Officer · Since at least Jun 11, 2019); Inozyme Pharma Inc (Director · Oct 3, 2024 – Oct 3, 2024 · Past); Denali Therapeutics Inc. (Director · Feb 3, 2022 – May 31, 2024 · Past)
Board Member · Since at least Mar 25, 2025
Gil Labrucherie
Other companies: Septerna, Inc. (Chief Financial Officer · Since at least Jan 6, 2025); Acelyrin, Inc. (CFO and CBO · Oct 4, 2023 – Aug 31, 2024 · Past)
Director · Since at least Jan 23, 2024
Nerissa Kreher
Other companies: Xeris Biopharma Holdings, Inc. (Independent, Non-executive Board Member · Since at least Jun 30, 2026); Entrada Therapeutics, Inc. (Chief Medical Officer · Jul 1, 2022 – Sep 1, 2023 · Past)
Board Member · Since at least Jun 23, 2022
Daron Evans
Other companies: Nephros, Inc. (CEO of Specialty Renal Product · May 24, 2021 – May 24, 2021 · Past)
CFO · Since at least Jan 22, 2024
Morgan Fields
Other companies: Arq, Inc. (Chief Accounting Officer · Apr 1, 2021 – Aug 17, 2023 · Past)
Chief Accounting Officer · Jul 18, 2014 – Oct 31, 2016 · Past
Nevan Charles Elam
Other companies: Savara, Inc. (Director · Since at least Dec 2, 2025)
Chief Executive Officer & Founder · Since at least Jun 10, 2025
Barry Michael ShermanDirector · Jul 18, 2014 – Oct 31, 2016 · Past
Brian RobertsChief Medical Officer · Since at least Oct 23, 2020
Gil LabrucherieBoard Member · Since at least Nov 4, 2026
Michael R. DeperroSenior Vice President & Head of Operations · Since at least Nov 4, 2026
All 17 people
PersonSeat
Philippe FauchetBoard Member · Since at least Sep 10, 2020
Sankaram MantripragadaChief Scientific Officer · Jan 31, 2013 – Jul 31, 2019 · Past
Sunil KarnawatChief Commercial Officer · Since at least Aug 20, 2025
Susan StewartChief Regulatory Officer · Since at least Dec 3, 2024
Vlad HogenhuisBoard Member · Since at least Nov 4, 2026
Young Chul SungDirector · Feb 11, 2019 – Feb 11, 2019 · Past
Young-Jin KimBoard Member · Since at least Feb 11, 2019

Open People

Log in to ask 6ix AI your own questions about Rezolute, Inc.